List of works - Flavia C Vasconcelos

11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.

scientific article published on 12 August 2016

Analysis of survivin, XIAP and FoxM1 as potential chemoresistance factors in breast cancer cells.

scientific article published on 4 April 2013

CPT-11-induced cell death in leukemic cells is not affected by the MDR phenotype.

scientific article published in March 2003

Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.

scientific article published in December 1997

Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.

scientific article

Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil.

scientific article published on January 1998

Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice

scientific article published on 15 September 2006

Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.

scientific article published on 31 August 2013

Genomic variation at the MDR1 promoter and P-glycoprotein expression and activity in AML patients

scientific article published on 14 November 2007

Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia ⬇️

scientific article published on September 1, 1997

Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulation.

scientific article published in November 2008

P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells ⬇️

scientific article published on June 28, 2011

Phosphorylated Crkl reduction levels are associated with the lowest P-glycoprotein activity levels in cells from chronic myeloid leukemia patients.

scientific article published on 29 September 2013

Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia.

scientific article published on 4 May 2011

Survivin overexpression correlates with an apoptosis-resistant phenotype in chronic myeloid leukemia cells.

scientific article published on 22 March 2011

The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia.

scientific article published on 24 April 2012

Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients ⬇️

scientific article published on December 2, 2010

p53 flow cytometry evaluation in leukemias: correlation to factors affecting clinical outcome.